PRLD
Prelude·NASDAQ
--
--(--)
--
--(--)
PRLD fundamentals
Prelude (PRLD) released its earnings on Nov 12, 2025: revenue was 6.50M (YoY +116.67%), beat estimates; EPS was -0.26 (YoY +39.53%), beat estimates.
Revenue / YoY
6.50M
+116.67%
EPS / YoY
-0.26
+39.53%
Report date
Nov 12, 2025
PRLD Earnings Call Summary for Q3,2025
- Two Lead Programs in 2026: JAK2V617F inhibitor for MPN and KAT6A degrader for ER+ breast cancer.
- Incyte Deal: $60M upfront, up to $910M total, leveraging Incyte's MPN expertise.
- Selective Degradation: KAT6A degrader avoids dual inhibition toxicity, showing preclinical efficacy.
- Clinical Timelines: JAK2 Phase I H1 2026, KAT6A Phase I H2 2026.
Earnings
EPS
Revenue
Revenue & Expenses
PRLD has released its 2025 Q4 earnings report, with revenue of 5.64M, reflecting a YoY change of 41.00%, and net profit of -16.46M, showing a YoY change of 42.72%. The Sankey diagram below clearly presents PRLD's revenue sources and cost distribution.
Key Indicators
Prelude (PRLD) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Prelude (PRLD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Prelude (PRLD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Prelude (PRLD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Prelude (PRLD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Prelude (PRLD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Prelude's earnings call?What guidance did Prelude's management provide for the next earnings period?Did Prelude beat or miss consensus estimates last quarter?What were the key takeaways from Prelude’s earnings call?What factors drove the changes in Prelude's revenue and profit?What is Prelude's gross profit margin?What does Prelude do and what are its main business segments?What is Prelude's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
